Skip to content

Evaluating femtosecond laser assisted cataract and lens surgery

Prospective observational study to evaluate femtosecond laser lens fragmentation, anterior capsulotomy cataract and lens extraction surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN49681405
Enrollment
100
Registered
2012-08-30
Start date
2012-08-28
Completion date
Unknown
Last updated
2018-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract, refractive error Eye Diseases Other cataract

Interventions

This is an observational study of surgery outcomes.

Sponsors

Moorfields Eye Hospital (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Any subject planned to undergo femtosecond laser assisted lens surgery. These subjects will already meet these criteria: 1. Subjects must be adults (>16 years), undergoing refractive lens or cataract surgery 2. Subjects must provide informed consent, have signed the written informed consent form, and been given a copy 3. Subjects must have a calculated average corneal power after of = 50.00 D in the eye to be implanted 4. Subjects must have a pharmacologically dilated pupil >6.0 mm, in the eye to be implanted 5. The central anterior chamber depth must be >2.0 mm (Pentacam) 6. Subjects must be willing and able to return for scheduled follow up examinations for 3 months after surgery

Exclusion criteria

Exclusion criteria: 1. Subjects with subluxated crystalline lens 2. Subjects with endothelial dystrophy, guttata, in the eye to be implanted 3. Subjects with keratoconus (or keratoconus suspect) in the eye to be implanted or K>50 D 4. Subjects with distorted or unclear corneal mires on topography maps of the eye to be implanted 5. Subjects with a history of Herpes zoster or Herpes simplex keratitis. 6. The central anterior chamber depth <2.0 mm (Pentacam) 7. Tremor with head titubation 8. Subjects who are participating in any other ophthalmic drug or device clinical trial during the time of this clinical investigation

Design outcomes

Primary

MeasureTime frame
To record any complications or adverse events

Secondary

MeasureTime frame
To describe the ability of the intraocular femtosecond laser to successfully perform an anterior capsulotomy and phakofragmentation during cataract/lens surgery.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026